Which has stronger valuation & earnings, CERT or DOCS?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A Doximity $644.86M 7.19 $196.05M $0.85 30.58

Is CERT or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Doximity 25.48% 18.06% 15.40%

Does the media refer more to CERT or DOCS?

In the previous week, Doximity had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Doximity and 1 mentions for Certara. Doximity's average media sentiment score of 0.17 beat Certara's score of -0.40 indicating that Doximity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Doximity 4 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, CERT or WAY?

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A Waystar $1.10B 4.48 $112.09M $0.70 36.66

Is CERT or WAY more profitable?

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Waystar 11.18% 7.03% 4.75%

Does the media favor CERT or WAY?

In the previous week, Waystar had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Waystar and 1 mentions for Certara. Waystar's average media sentiment score of 0.31 beat Certara's score of -0.40 indicating that Waystar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Waystar 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, HTFL or CERT?

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 25.07 -$116.79M -$1.83 N/A Certara $418.84M 3.07 -$1.60M -$0.45 N/A

Is HTFL or CERT more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Certara -16.75% 3.86% 2.65%

Does the media prefer HTFL or CERT?

In the previous week, Heartflow had 28 more articles in the media than Certara. MarketBeat recorded 29 mentions for Heartflow and 1 mentions for Certara. Heartflow's average media sentiment score of 0.38 beat Certara's score of -0.40 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 11 Very Positive mention(s) 7 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, CERT or SDGR?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A Schrodinger $255.87M 8.37 -$103.26M -$0.74 N/A

Is CERT or SDGR more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Schrodinger -20.98% -16.37% -8.19%

Does the media favor CERT or SDGR?

In the previous week, Schrodinger had 11 more articles in the media than Certara. MarketBeat recorded 12 mentions for Schrodinger and 1 mentions for Certara. Schrodinger's average media sentiment score of 0.64 beat Certara's score of -0.40 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, GDRX or CERT?

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.45 $30.44M $0.04 84.50 Certara $418.84M 3.07 -$1.60M -$0.45 N/A

Is GDRX or CERT more profitable?

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Certara -16.75% 3.86% 2.65%

Certara (CERT) Competitors

$8.42 -0.16 (-1.86%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$8.49 +0.07 (+0.89%)

As of 09/18/2026 07:30 PM Eastern

Compare

CERT vs. DOCS, WAY, HTFL, SDGR, and GDRX

Should you buy Certara stock or one of its competitors? Certara's main competitors and comparable companies include Doximity (DOCS), Waystar (WAY), Heartflow (HTFL), Schrodinger (SDGR), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Certara compare to Doximity?

Certara (NASDAQ:CERT) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Doximity	25.48%	18.06%	15.40%

74.0% of Certara shares are held by institutional investors. Comparatively, 87.2% of Doximity shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 31.8% of Doximity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
Doximity	$644.86M	7.19	$196.05M	$0.85	30.58

Certara has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, Doximity has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market.

In the previous week, Doximity had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Doximity and 1 mentions for Certara. Doximity's average media sentiment score of 0.17 beat Certara's score of -0.40 indicating that Doximity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Doximity	4 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Certara currently has a consensus target price of $8.28, suggesting a potential downside of 1.69%. Doximity has a consensus target price of $32.18, suggesting a potential upside of 23.80%. Given Doximity's higher probable upside, analysts clearly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31

Summary

Doximity beats Certara on 15 of the 17 factors compared between the two stocks.

How does Certara compare to Waystar?

Certara (NASDAQ:CERT) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Waystar	11.18%	7.03%	4.75%

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 3.5% of Waystar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Certara has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market. Comparatively, Waystar has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market.

In the previous week, Waystar had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Waystar and 1 mentions for Certara. Waystar's average media sentiment score of 0.31 beat Certara's score of -0.40 indicating that Waystar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Waystar	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara presently has a consensus price target of $8.28, indicating a potential downside of 1.69%. Waystar has a consensus price target of $34.67, indicating a potential upside of 35.10%. Given Waystar's stronger consensus rating and higher possible upside, analysts clearly believe Waystar is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
Waystar	$1.10B	4.48	$112.09M	$0.70	36.66

Summary

Waystar beats Certara on 15 of the 17 factors compared between the two stocks.

How does Certara compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Heartflow presently has a consensus price target of $44.88, suggesting a potential downside of 11.58%. Certara has a consensus price target of $8.28, suggesting a potential downside of 1.69%. Given Certara's higher possible upside, analysts clearly believe Certara is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45

74.0% of Certara shares are held by institutional investors. 7.7% of Heartflow shares are held by insiders. Comparatively, 1.1% of Certara shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Certara	-16.75%	3.86%	2.65%

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	25.07	-$116.79M	-$1.83	N/A
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A

In the previous week, Heartflow had 28 more articles in the media than Certara. MarketBeat recorded 29 mentions for Heartflow and 1 mentions for Certara. Heartflow's average media sentiment score of 0.38 beat Certara's score of -0.40 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	11 Very Positive mention(s)	7 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Certara beats Heartflow on 9 of the 15 factors compared between the two stocks.

How does Certara compare to Schrodinger?

Certara (NASDAQ:CERT) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
Schrodinger	$255.87M	8.37	-$103.26M	-$0.74	N/A

Certara currently has a consensus price target of $8.28, indicating a potential downside of 1.69%. Schrodinger has a consensus price target of $20.50, indicating a potential downside of 29.36%. Given Certara's stronger consensus rating and higher possible upside, analysts clearly believe Certara is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

In the previous week, Schrodinger had 11 more articles in the media than Certara. MarketBeat recorded 12 mentions for Schrodinger and 1 mentions for Certara. Schrodinger's average media sentiment score of 0.64 beat Certara's score of -0.40 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

74.0% of Certara shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 10.1% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Schrodinger	-20.98%	-16.37%	-8.19%

Certara has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market.

Summary

Certara beats Schrodinger on 11 of the 17 factors compared between the two stocks.

How does Certara compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Certara	-16.75%	3.86%	2.65%

63.8% of GoodRx shares are held by institutional investors. Comparatively, 74.0% of Certara shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Comparatively, 1.1% of Certara shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.45	$30.44M	$0.04	84.50
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A

In the previous week, Certara had 1 more articles in the media than GoodRx. MarketBeat recorded 1 mentions for Certara and 0 mentions for GoodRx. GoodRx's average media sentiment score of 0.00 beat Certara's score of -0.40 indicating that GoodRx is being referred to more favorably in the media.

Company	Overall Sentiment
GoodRx	Neutral
Certara	Neutral

GoodRx currently has a consensus target price of $4.23, indicating a potential upside of 25.07%. Certara has a consensus target price of $8.28, indicating a potential downside of 1.69%. Given GoodRx's higher probable upside, equities analysts plainly believe GoodRx is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45

GoodRx has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market. Comparatively, Certara has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Summary

GoodRx beats Certara on 10 of the 16 factors compared between the two stocks.

Get Certara News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CERT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CERT vs. The Competition

Export

Metric	Certara	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.28B	$1.72B	$7.24B	$13.19B
Dividend Yield	N/A	4.71%	2.57%	12.81%
P/E Ratio	-18.71	20.07	275.49	25.40
Price / Sales	3.07	89.94	646.01	89.45
Price / Cash	11.13	31.60	76.25	51.42
Price / Book	1.26	6.14	10.46	6.33
Net Income	-$1.60M	-$18.66M	$3.49B	$358.33M
7 Day Performance	11.52%	1.79%	0.59%	1.12%
1 Month Performance	-3.55%	1.77%	-1.74%	-2.39%
1 Year Performance	-26.66%	-14.53%	18.13%	5.35%

Certara Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CERT Certara	0.9784 of 5 stars	$8.42 -1.9%	$8.28 -1.7%	-26.7%	$1.28B	$418.84M	N/A	1,576	Positive News High Trading Volume
DOCS Doximity	4.5287 of 5 stars	$26.38 +3.1%	$32.18 +22.0%	N/A	$4.56B	$644.86M	31.03	880	Trending News
WAY Waystar	4.3639 of 5 stars	$24.90 +6.1%	$35.14 +41.1%	-32.1%	$4.50B	$1.21B	35.57	1,700	Analyst Downgrade
HTFL Heartflow	2.0321 of 5 stars	$49.54 -0.7%	$44.88 -9.4%	+54.3%	$4.31B	$212.07M	N/A	843	News Coverage Insider Trade
SDGR Schrodinger	0.9501 of 5 stars	$20.75 +9.1%	$20.50 -1.2%	+49.2%	$1.40B	$259.04M	N/A	850	News Coverage Options Volume Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CERT) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Certara (CERT) Competitors